pentobarbital will reduce the extent or result of bedaquiline by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Steer clear of or Use Alternate Drug. Avoid coadministration of bedaquiline with sturdy CYP3A4 inducers as a consequence of prospective for lessened therapeutic effect pentobarb